Samuel R. Saks, Chief Executive Officer at JAZZ PHARMACEUTICALS INC (JAZZ), bought 4,900 shares at $13.40 ($66K) on 2007-11-14, disclosed to the SEC on 2007-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.38 | 900 | $12K | 18.3% |
| 2 | $13.40 | 4,000 | $54K | 81.7% |
| Total | $13.40 avg | 4,900 | $66K | 100% |
| Filing → |
| TNXP | BUY | 2015-07-17 | $75K | — | Filing → |
| ASPX | BUY | 2014-02-12 | $26K | — | Filing → |
| JAZZ | BUY | 2007-11-14 | $318K | — | Filing → |